Executive Overview The AI revolution is far more than a technical shift; it represents a profound psychological disruption for the... Read more
Category: Uncategorized
Pink on the Square – A symbol of solidarity and survival at JPM 2026
Amid the traditional sea of navy and gray at the J.P. Morgan Healthcare Conference in San Francisco, flashes of pink... Read more
AstraZeneca secures full global rights to AbelZeta’s CAR-T therapy in $630M deal
AstraZeneca has reached a definitive agreement to acquire the remaining 50% stake in the Chinese development and commercialization rights for... Read more
J&J partners with Alphabet’s Isomorphic Labs for AI-driven drug discovery
Johnson & Johnson’s Janssen Biotech unit has signed a multi-target research collaboration with Isomorphic Labs, an Alphabet-backed startup at the... Read more
GSK acquires RAPT Therapeutics for $2.2B to strengthen food allergy pipeline
GSK has entered into a definitive agreement to acquire California-based RAPT Therapeutics for $58.00 per share, representing a total equity... Read more
Synbio to trial AI facial screening for mental health detection in Australia
Synbio International has partnered with CRO Services Pty – a subsidiary of Resonance Health – to conduct a clinical trial... Read more
Genentech doubles Holly Springs investment to $2B for metabolic drug production
Genentech, a member of the Roche Group, has announced a significant expansion of its initial investment in a new manufacturing... Read more
GSK Subsidiary Tesaro signs $285M deal for subcutaneous cancer drug technology
Tesaro, an oncology-focused subsidiary of GSK, has entered into a global licensing agreement with South Korea’s Alteogen to develop a... Read more
Worldwide Clinical Trials to acquire Catalyst Clinical Research in strategic oncology push
Global contract research organization (CRO) Worldwide Clinical Trials has entered into a definitive agreement to acquire Catalyst Clinical Research. The... Read more









